Approved indications: This medicine is used to numb part of the mouth (local, infiltrative, or nerve block anesthesia) so that simple or complex dental procedures can be performed comfortably in adults and children 4 years and older.

Off-label uses: Dentists may use different injection techniques (such as buccal infiltrations instead of nerve blocks for some lower molar treatment), but use is essentially limited to in‑office dental anesthesia and it is not intended as a general pain medicine or for non‑dental procedures.

Efficacy expectations: Numbness usually begins within a few minutes of injection, provides reliable tooth (pulpal) anesthesia for roughly an hour and soft‑tissue numbness for several hours, and clinical studies show success rates that are at least comparable and often superior to 2% lidocaine with epinephrine, especially for some infiltrations, with a similar overall duration of comfortable treatment time.

How it is given and typical doses: Articaine hydrochloride and epinephrine is given only by a dental professional as an intraoral submucosal injection (local infiltration or nerve block), with typical volumes for healthy adults of about 0.5–2.5 mL for infiltrations, 0.5–3.4 mL for nerve blocks, and 1–5.1 mL for oral surgery, while keeping the total dose at or below 7 mg/kg (0.175 mL/kg) of articaine; children 4–16 years are dosed by weight up to the same per‑kg maximum and the dentist limits the number of cartridges used.

Special dosing instructions: The smallest amount that provides effective numbness is used, and lower total doses are chosen in elderly, frail, acutely ill, or severe liver‑disease patients; injections are given slowly with aspiration to reduce the risk of accidental intravascular injection, and there are no specific requirements regarding food, but most dentists prefer you not chew on the numb area until sensation returns.

Missed doses and overdose: Because this medicine is only administered in the dental office, “missed doses” mainly mean that if numbness is insufficient the dentist may give an additional carefully calculated injection, whereas overdose can cause symptoms such as ringing in the ears, metallic taste, numb tongue, dizziness, agitation, confusion, seizures, very slow or irregular heartbeat, or breathing problems, all of which require immediate management by the dental team and, if needed, emergency medical services.

Common side effects: Temporary numbness, tingling, or swelling of the lips, tongue, or cheek, mild pain or tenderness at the injection site, jaw stiffness, headache, and brief feelings of nervousness, shakiness, or a fast heartbeat from the epinephrine are relatively common and usually mild and short‑lived.

Serious or rare adverse effects: Seek immediate medical attention for signs of a severe allergic or sensitivity reaction (hives, rash, swelling of the face or throat, trouble breathing), seizures, confusion, fainting, chest pain, irregular or very fast heartbeat, extreme drowsiness, or signs of methemoglobinemia such as gray‑ or blue‑colored lips or fingers, shortness of breath, unusual fatigue, or rapid heartbeat.

Warnings and precautions: This anesthetic should generally be avoided in people with known allergies to amide local anesthetics or sulfites and used cautiously in those with serious heart disease (recent heart attack, significant arrhythmias, uncontrolled high blood pressure, severe heart failure), uncontrolled hyperthyroidism, severe liver disease, seizure disorders, asthma with sulfite sensitivity, or a history or risk of methemoglobinemia; safety and effectiveness have not been established in children under 4 years, and limited human data mean it is used in pregnancy or during breastfeeding only when the expected benefit justifies potential risks.

Safety compared with similar drugs: Overall, articaine with epinephrine has a safety profile similar to other amide local anesthetics used in dentistry, though some reports suggest that 4% solutions (including articaine) may have a slightly higher risk of prolonged numbness or nerve symptoms after certain mandibular nerve blocks, while the absolute risk of such complications remains very low.

Reporting side effects and safety updates: In the United States, side effects can be reported to the FDA MedWatch program or to the manufacturer, and updated safety information is available through the FDA and product labeling that your dentist or pharmacist can review with you.

Drug and substance interactions: The epinephrine component can interact with medicines that affect heart rhythm or blood pressure, including nonselective beta‑blockers (such as propranolol), some antiarrhythmics, tricyclic antidepressants, MAO inhibitors, many stimulant drugs (including amphetamines and some ADHD medications), and cocaine, as well as OTC decongestants containing pseudoephedrine or similar agents, potentially increasing blood pressure or heart rate; using other local anesthetics at the same visit adds to total anesthetic exposure, and alcohol, sedatives, or opioids may enhance drowsiness or blood‑pressure changes, although significant interactions are less common because the injection is localized and short‑acting.

Conditions requiring extra caution or avoidance: Use requires special care, or may be avoided altogether, in people with severe ischemic heart disease or recent heart attack, significant arrhythmias, uncontrolled hypertension, severe heart failure, recent stroke, untreated hyperthyroidism, pheochromocytoma, poorly controlled diabetes, seizure disorders, severe liver disease, known or suspected methemoglobinemia or certain anemias (including some forms of G6PD deficiency), asthma with sulfite sensitivity, or known allergy to amide local anesthetics or sulfites, and it is not recommended for children younger than 4 years.

Monitoring: During dental treatment, clinicians typically monitor your level of alertness and watch for symptoms, and in patients with significant cardiovascular or other serious conditions they may also check blood pressure and heart rate before and after injection and, when appropriate, coordinate with your physician for additional monitoring or adjustments to other medicines.

Q: How long will my mouth stay numb after articaine with epinephrine?
A: Most people feel tooth numbness for about 60–90 minutes and numbness of the lips, tongue, and cheek for a few hours, depending on the dose, injection site, and individual response.

Q: Is this anesthetic safe for children?
A: It is approved for children 4 years and older when the dose is adjusted to body weight, but it is not established as safe or effective in children under 4 years, and parents should watch closely so children do not bite or injure their numb lips or cheeks.

Q: Can I drive or go back to work after getting this injection?
A: Most adults can safely drive and return to normal activities once the dental procedure is finished, as long as they do not feel dizzy or unusually drowsy and avoid eating or drinking hot foods until the numbness has mostly worn off.

Q: Why did my heart start racing when the dentist injected the anesthetic?
A: The epinephrine in the injection can temporarily raise your heart rate and blood pressure, causing a feeling of pounding heart or shakiness that usually begins within seconds and fades within a few minutes.

Q: What should I do if my mouth stays numb or tingles for many hours?
A: Prolonged numbness for several hours can be normal, but if tingling, weakness, or altered sensation persists into the next day or seems to be getting worse, you should contact your dentist so they can evaluate you for possible nerve irritation or other rare complications.